--- title: Newsroom | Pharma (5) description: Pharma | (5) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”](https://news.lifesciencenewswire.com/newsroom/new-lonza-webinar-taking-the-leap-into-an-mes-from-a-ceos-perspective) April 20, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/new-lonza-webinar-taking-the-leap-into-an-mes-from-a-ceos-perspective) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/new-lonza-webinar-taking-the-leap-into-an-mes-from-a-ceos-perspective#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 20, 2023, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Tillotts Pharma AG announces the launch of Octasa® 1600 mg Tablets in Canada](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-ag-announces-the-launch-of-octasa-1600-mg-tablets-in-canada) April 6, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-ag-announces-the-launch-of-octasa-1600-mg-tablets-in-canada) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-ag-announces-the-launch-of-octasa-1600-mg-tablets-in-canada#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 6, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18](https://news.lifesciencenewswire.com/newsroom/remedium-and-exothera-partner-on-scale-up-and-demonstration-runs-for-aav2-fgf18) March 22, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/remedium-and-exothera-partner-on-scale-up-and-demonstration-runs-for-aav2-fgf18) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/remedium-and-exothera-partner-on-scale-up-and-demonstration-runs-for-aav2-fgf18#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 22, 2023, 8:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [NDA Group welcomes Marianne Scheel Fjording, Ph.D. to the NDA Advisory Board adding essential expertise in bioanalysis and immunogenicity assessment to the team](https://news.lifesciencenewswire.com/newsroom/nda-group-welcomes-marianne-scheel-fjording-ph.d.-to-the-nda-advisory-board-adding-essential-expertise-in-bioanalysis-and-immunogenicity-assessment-to-the-team) March 7, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/nda-group-welcomes-marianne-scheel-fjording-ph.d.-to-the-nda-advisory-board-adding-essential-expertise-in-bioanalysis-and-immunogenicity-assessment-to-the-team) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/nda-group-welcomes-marianne-scheel-fjording-ph.d.-to-the-nda-advisory-board-adding-essential-expertise-in-bioanalysis-and-immunogenicity-assessment-to-the-team#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 7, 2023, 11:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) #### [pharma& chooses Generis’ CARA Life Sciences Platform to become the basis of its Regulatory, Quality and Legal Management System](https://news.lifesciencenewswire.com/newsroom/pharma-chooses-generis-cara-life-sciences-platform-to-become-the-basis-of-its-regulatory-quality-and-legal-management-system) February 22, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/pharma-chooses-generis-cara-life-sciences-platform-to-become-the-basis-of-its-regulatory-quality-and-legal-management-system) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/pharma-chooses-generis-cara-life-sciences-platform-to-become-the-basis-of-its-regulatory-quality-and-legal-management-system#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 22, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) #### [TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research](https://news.lifesciencenewswire.com/newsroom/transcure-bioservices-offers-biovolume-3d-imaging-for-insightful-preclinical-oncology-research) February 2, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/transcure-bioservices-offers-biovolume-3d-imaging-for-insightful-preclinical-oncology-research) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/transcure-bioservices-offers-biovolume-3d-imaging-for-insightful-preclinical-oncology-research#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 2, 2023, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Exothera announces the appointment of Darren Leva as Chief Business Officer](https://news.lifesciencenewswire.com/newsroom/exothera-announces-the-appointment-of-darren-leva-as-chief-business-officer) February 1, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/exothera-announces-the-appointment-of-darren-leva-as-chief-business-officer) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/exothera-announces-the-appointment-of-darren-leva-as-chief-business-officer#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 1, 2023, 8:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [German pharma company selects Generis’ CARA Life Sciences Platform to unify their clinical processes](https://news.lifesciencenewswire.com/newsroom/german-pharma-company-selects-generis-cara-life-sciences-platform-to-unify-their-clinical-processes) January 18, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/german-pharma-company-selects-generis-cara-life-sciences-platform-to-unify-their-clinical-processes) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/german-pharma-company-selects-generis-cara-life-sciences-platform-to-unify-their-clinical-processes#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 18, 2023, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Global pharmaceutical company Merz choose Generis’ CARA Life Sciences Platform to consolidate their R&D content](https://news.lifesciencenewswire.com/newsroom/global-pharmaceutical-company-merz-choose-generis-cara-life-sciences-platform-to-consolidate-their-rd-content) December 19, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/global-pharmaceutical-company-merz-choose-generis-cara-life-sciences-platform-to-consolidate-their-rd-content) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/global-pharmaceutical-company-merz-choose-generis-cara-life-sciences-platform-to-consolidate-their-rd-content#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 19, 2022, 12:30:00 PM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/tag/pharma/page/4) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/pharma/page/6) ##### Browse more news ## Recent releases #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) #### [CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and...](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development) October 1, 2026 The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-and-imagene-ai-expand-collaboration-to-validate-deploy-and-scale-ai-powered-biomarker-and-companion-diagnostic-programs-across-drug-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)